<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04690023</url>
  </required_header>
  <id_info>
    <org_study_id>2020/381</org_study_id>
    <nct_id>NCT04690023</nct_id>
  </id_info>
  <brief_title>PENG Block vs Supra-inguinal Fascia Iliaca Compartment Block for Postoperative Opioids Consumption and Early Motor Recovery After THA: a Randomized Controlled Non-inferiority Clinical Trial.</brief_title>
  <official_title>Comparison of Ultrasound-guided PENG Block and Supra-inguinal Fascia Iliaca Compartment Block for Postoperative Opioids Consumption and Early Motor Recovery After Total Hip Arthroplasty: a Randomized Controlled Non-inferiority Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Liege</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Liege</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the impact of pericapsular nerve group block (PENG) versus the supra-inguinal&#xD;
      fascia-iliaca compartment block (SFICB) in postoperative analgesia, opioid sparing and&#xD;
      enhanced recovery after surgery of total hip arthroplasty by poster-lateral approach.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ASA physical status 1, 2 and 3 patients scheduled to undergo elective total hip arthroplasty&#xD;
      by poster-lateral (Moore) surgical approach with spinal anesthesia.&#xD;
&#xD;
      The investigators want to confirm the non-inferiority of the SFICB compared to the PENG block&#xD;
      on postoperative first 6 hours after surgery NRS pain score and 48 hours opioids consumption,&#xD;
      and the difference between these in terms of early recovery and motor impact on two first day&#xD;
      after surgery. The principal investigator perform these regional anesthesia techniques with&#xD;
      ultrasound guided injections.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Non-inferiority randomized controlled clinical trial</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Non-inferiority controlled RCT with two groups simple-blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>NRS 6 hours</measure>
    <time_frame>6 hours after surgery</time_frame>
    <description>The primary endpoint of the study will be the between-group comparisons in postoperative NRS pain scores on 0 to 10 scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>6 minutes walk test</measure>
    <time_frame>48 jours after surgery</time_frame>
    <description>Difference in traveled distance (metres) at six minutes walking test 48 hours after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioids secondaires side effects</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>Incidence of morphine related side effects in two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QoR-15</measure>
    <time_frame>72 hours after surgery</time_frame>
    <description>QoR-15 French validated questionnaire for the evaluation of recovery after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2 minutes walk test</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Difference in traveled distance (metres) at two minutes walking test 24 hours after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid sparing</measure>
    <time_frame>48 hours after intervention</time_frame>
    <description>Difference in cumulated morphine consumption in first 48 hours after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DN4</measure>
    <time_frame>72 hours after surgery</time_frame>
    <description>Difference between the two groups in the DN4 questionnaire to assess the risk of persistent pain after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IPO</measure>
    <time_frame>72 hours after surgery</time_frame>
    <description>Pain management satisfaction score by revised American Pain Society Patient Outcomes Questionnaire (APS- POQ-R).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Total Hip Arthroplasty</condition>
  <arm_group>
    <arm_group_label>PENG block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients scheduled for total hip arthroplasty with spinal anesthesia receive before intra-thecal injection, ultrasound-guided PENG block. Patients in PENG group receive multimodal postoperative analgesia techniques coupled with morphine PCA pump.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SFICB block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients scheduled for total hip arthroplasty with spinal anesthesia receive before intra-thecal injection, ultrasound-guided supra-inguinal fascia iliaca compartment block. Patients in SFICB group receive multimodal postoperative analgesia techniques coupled with morphine PCA pump.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pericapsular nerves group (PENG) block</intervention_name>
    <description>Patients scheduled for total hip arthroplasty with spinal anesthesia receive before intra-thecal injection, ultrasound-guided PENG block with injection 20 ml of ropivacaine 0,75%, between the anterior hip articular capsule, the ilii-psoas muscle, the ileo-pubic eminence and the antero-inferior iliac spine.</description>
    <arm_group_label>PENG block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Supra-inguinal fascia-iliaca compartment block</intervention_name>
    <description>Patients scheduled for total hip arthroplasty with spinal anesthesia receive before intra-thecal injection, ultrasound-guided supra-inguinal fascia iliaca compartment block with injection over de inguinal ligament of 40 ml of ropivacaine 0,375%, between de ilio-psoas muscle and internal oblique muscle.</description>
    <arm_group_label>SFICB block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0,75% in PENG block</intervention_name>
    <description>20 ml injection of ropivacaine 0,75%</description>
    <arm_group_label>PENG block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0,375% in SFICB block</intervention_name>
    <description>40 ml injection of ropivacaine 0,375%</description>
    <arm_group_label>SFICB block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Adults patients scheduled to undergo elective primary total hip arthroplasty by posterior&#xD;
        surgical approach with spinal anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal&#xD;
&#xD;
          -  Allergy to administrated drugs or local infection&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  History of chronic pain&#xD;
&#xD;
          -  Drugs addiction&#xD;
&#xD;
          -  Mental ou neurological diseases&#xD;
&#xD;
          -  Kidney or liver serious diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michele Carella, MD</last_name>
    <phone>003242843658</phone>
    <email>mcarella@chuliege.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Liège</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Girón-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A. Pericapsular Nerve Group (PENG) Block for Hip Fracture. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847.</citation>
    <PMID>30063657</PMID>
  </reference>
  <reference>
    <citation>Vermeylen K, Desmet M, Leunen I, Soetens F, Neyrinck A, Carens D, Caerts B, Seynaeve P, Hadzic A, Van de Velde M. Supra-inguinal injection for fascia iliaca compartment block results in more consistent spread towards the lumbar plexus than an infra-inguinal injection: a volunteer study. Reg Anesth Pain Med. 2019 Feb 22. pii: rapm-2018-100092. doi: 10.1136/rapm-2018-100092. [Epub ahead of print]</citation>
    <PMID>30798268</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>December 28, 2020</study_first_submitted>
  <study_first_submitted_qc>December 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 30, 2020</study_first_posted>
  <last_update_submitted>September 2, 2021</last_update_submitted>
  <last_update_submitted_qc>September 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Liege</investigator_affiliation>
    <investigator_full_name>Jean François Brichant</investigator_full_name>
    <investigator_title>Head of Anesthesiology Departement</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

